Dr. Ulrich Rümenapp works within the biological development organisation of Bayer AG, where he is responsible for the transfer of Bayer’s pipeline candidates (antibodies and antibody drug conjugates) to external manufacturing partners and regulatory submission and launch preparations. Prior to working in development, Ulrich was head of biotech projects in product supply biotech at Bayer, where he was responsible for contract manu­facturing partnerships in the field of biotech¬nological drug substances, drug products and interdisciplinary project management with the goal to ensure market supply. Before it was acquired by Bayer, he held a similar position at Schering AG, and before that he worked in the production and logistics department of Schering. Ulrich studied chemistry and holds a PhD in biosciences. He has several years of experience in academic research in the field of signal transduction and as an assistant teacher in the field of general pharmacology. Currently, his area of expertise is the setup and management of external relationships for the development and supply of bio-pharmaceutical products.

James is based in the UK with a global support role at F Ziel (Germany) who manufacture technologies for environmental control in sterile pharmaceuticals & ATMP manufacturing. Together with the role at F Ziel James is Ex-Chairman and an honorary member of the Not-for-Profit PHSS: Pharmaceutical & Healthcare Sciences Society. Working experience includes 10 years in radio pharmaceutical manufacturing and over 30 years working in sterile medicinal product manufacturing support where increasingly aseptic processing applies to ATMPs, particularly Gene and Cell therapies. James is a Subject matter expert in Barrier Technology (Isolators and RABS) and Bio-decontamination with Hydrogen peroxide vapour (H202-VHP). James is also a Member of ISPE and PDA UK Chapter Board member.

Christa Myers has been in the pharmaceutical industry for over 25 years and is a leader and subject matter expert. Christa is a well-recognized speaker at conferences and is frequently on-stage teaching others about regulatory requirements, operational issues and what to expect in the future of the in­dustry. Christa champions approaches that integrate strong project execution and technical solutions. Christa is on the steering committee for the ISPE community of practice for sterile products processing, a certified ISPE instructor of the sterile product processing baseline guide, the chair of ISPE’s women in pharma group, as well as an author of the most recent ISPE sterile processing baseline guide. Christa provides guidance and leadership to clients on how and when to utilise common or innovative solutions and continuously promotes the technical growth of people willing to learn more to advance the industry. She was recently awarded an honour as one of the 2019 Influential Women in Manufacturing.

Fred Ohsiek, who earned his BS in Chemistry from University of South Florida, resides in the NC RDU area. He has 25 plus years of validation experience as an FTE and Consultant, while specializing in cleaning validation.

He has been fortunate to work for 7 major pharmaceuticals (Catalent, AstraZeneca, Boehringer Ingelheim, Teva, Astellas, Bayer, and Novo Nordisk) where he was considered the cleaning validation SME in most of his roles. Working with various routes of administration (OSD, parenteral, topical, and softgels) in green and brown field small and large molecule manufacturing projects has provided Fred with a very broad range of experience.

Fred also obtained “cleaning chemistry” experience while working as a Sr Global Technical Manager at Ecolab (Life Science division).

As Associate Director of Cleaning Validation at Eliquent Life Sciences, he and his team support industry by authoring tailored justifications, reducing the validation footprint via risk assessments, creating startup CV programs, remediating legacy processes, and increasing manufacturing capability.

He was one of the authors of the ISPE Cleaning Validation Lifecycle – Application, Methods, and Controls guidance, and he regularly presents at conferences nationally and globally.

Justin Mason-Home is an organic chemist with extensive health, safety, environmental, and chemical engineering experience in senior technical, legal, and commercial aspects of the pharmaceutical, biochemical, chemical, and other industries. He is a Fellow of the Royal Society of Chemistry in the United Kingdom.

Justin started as a research chemist in the flavour and fragrance sector, researching and discovering new chemical synthetic routes to produce nature-identical flavour and fragrance components. In the fine chemical sector, he worked through scale-up (Kilo Lab then Pilot Plant) to full-scale manufacture. After a move to corporate environmental management, Justin was head-hunted into environmental consulting, heading a technical environmental engineering function.

He has since held senior positions and worked globally in potent biopharmaceutical occupational health and safety global environmental consulting, he's held a board level position in a biotechnology company, and has worked in corporate environmental management. Justin has been involved in and worked on potent and highly-potent API projects for more than 22 years and specialises in technical complex and strategic projects, including unique experience in managing sensitive highly-potent and toxic biopharmaceutical compound matters. Justin has chaired, presented at, and attended many HPAPI events and is a recognised expert in this area.

Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, phar­maceutical engineering, and quality control at the University of Applied Sciences in Albstadt/Sigmaringen, Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert con­tainment group of the ISPE DACH eight years ago. The containment group published the containment manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.